Heads Up??? I received this email this morning -
Post# of 103030
RE:
Weed2016 Member Level
Thursday, February 9, 2017 11:12:44 PM
IDGC #$$$
MUST READ IDGC SHAREHOLDERS
WE Thought we owned 1 MILLION SHARES OF PYHH
TURNS OUT WE OWN 1 MILLION + 8 MILLION MORE = 9 MILLION TOTAL
PYHH 9 million shares x $0.71 = $6.4 million divided by 5.7 billion shares total = $0.0011 PER SHARE IDGC SHOULD BE TRADING AT
? INVESTMENT HOLDINGS
https://www.otcmarkets.com/ajax/showFinancial...?id=165696
The Company owns 1,000,000 shares of common stock in PYHH. This constitutes a
Level I asset because there are quoted prices for the stock in an active market, and is therefore
valued at $0.15 per share, the market price on the balance sheet date. The company has
recently hired Kyle Charles Young Attorney out of Palm Beach, Florida to assist the company in
deciding a course of action regarding the deposit and sale of the PYHH Shares. These shares
were acquired as compensation from a consulting agreement with PYHH in 5/2013, the
company and Transfer Agent has blocked the legend removal from the certificate and neither
has given a valid legal argument for their actions.
The Company owns 198,385 shares of Series B Convertible Preferred Stock in PHYH. Each
share can be converted into 40 shares of common stock, a total of 7,935,400 common
shares if they were all converted. This constitutes a Level III asset because there are no current
quoted prices for the identical common stock in an active market, and is therefore valued at $0
per common share equivalent, the market price of the common stock on the balance sheet date.
The Company owns 500,000 shares of common stock in Jack Rockwell, Inc. This constitutes a
Level 3 asset because it is a startup private company in which there is no reliable way
to determine the fair market value. The Company invested $25,000 during the three
months ended December 31, 2016 and no fair value adjustments have been made.
The company also has two issued patents with the USPTO and has one IP Valuation on one of
the issued patents valued in excess of $5 million dollars US. The valuation report will be
released with these Q2 Financials